253 related articles for article (PubMed ID: 20040609)
1. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.
Dabbagh O; Oza A; Prakash S; Sunna R; Saettele TM
Chest; 2010 May; 137(5):1145-9. PubMed ID: 20040609
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Cohort Analysis of Pharmacologic VTE Prophylaxis and Padua Prediction Score in Hospitalized Patients With Chronic Liver Disease.
Moorehead KJ; Jeffres MN; Mueller SW
J Pharm Pract; 2017 Feb; 30(1):58-63. PubMed ID: 26475125
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pharmacologic prophylaxis for venous thromboembolism in patients with chronic liver disease.
Barclay SM; Jeffres MN; Nguyen K; Nguyen T
Pharmacotherapy; 2013 Apr; 33(4):375-82. PubMed ID: 23553808
[TBL] [Abstract][Full Text] [Related]
4. Risk of hemorrhage in patients with chronic liver disease and coagulopathy receiving pharmacologic venous thromboembolism prophylaxis.
Reichert JA; Hlavinka PF; Stolzfus JC
Pharmacotherapy; 2014 Oct; 34(10):1043-9. PubMed ID: 25052037
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of venous thromboembolism prophylaxis in patients with chronic liver disease.
Smith CB; Hurdle AC; Kemp LO; Sands C; Twilla JD
J Hosp Med; 2013 Oct; 8(10):569-73. PubMed ID: 24101541
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
Pincus KJ; Tata AL; Watson K
Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
[TBL] [Abstract][Full Text] [Related]
7. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
Yang LS; Alukaidey S; Croucher K; Dowling D
Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
[TBL] [Abstract][Full Text] [Related]
8. Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centers.
Khanna R; Maynard G; Sadeghi B; Hensley L; Medvedev S; Danielsen B; White RH
J Hosp Med; 2014 Apr; 9(4):221-5. PubMed ID: 24497463
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in coagulopathic surgical intensive care unit patients: is there a benefit from chemical prophylaxis?
Edwards M; Felder S; Ley E; Srour M; Mirocha J; Margulies DR; Salim A
J Trauma; 2011 Jun; 70(6):1398-400. PubMed ID: 21817976
[TBL] [Abstract][Full Text] [Related]
10. Majority of Total Joint Arthroplasties Are Subtherapeutic on Warfarin at Time of Discharge: Another Reason to Avoid Warfarin as a Venous Thromboembolism Prophylaxis?
Rondon AJ; Goswami K; Tan TL; Shohat N; Parvizi J
J Arthroplasty; 2018 Sep; 33(9):2787-2791. PubMed ID: 29871833
[TBL] [Abstract][Full Text] [Related]
11. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
Cox JB; Weaver KJ; Neal DW; Jacob RP; Hoh DJ
J Neurosurg Spine; 2014 Oct; 21(4):677-84. PubMed ID: 25105337
[TBL] [Abstract][Full Text] [Related]
12. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH
Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in patients with liver diseases.
Barba R; Gonzalvez-Gasch A; Joya Seijo D; Marco J; Canora J; Plaza S; Angelina García M; Zapatero A
J Thromb Haemost; 2018 Oct; 16(10):2003-2007. PubMed ID: 30066476
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic prophylaxis against venous thromboembolism in hospitalized patients with cirrhosis and associated coagulopathies.
Koliscak L; Maynor L
Am J Health Syst Pharm; 2012 Apr; 69(8):658-63. PubMed ID: 22472867
[TBL] [Abstract][Full Text] [Related]
15. Should patients with chronic liver disease receive venous thromboembolism prophylaxis?
Dang JD; Davis LE
JAAPA; 2015 Jun; 28(6):27-8, 30. PubMed ID: 25989432
[TBL] [Abstract][Full Text] [Related]
16. Correlates, Trends, and Short-Term Outcomes of Venous Thromboembolism in Hospitalized Patients with Hepatocellular Carcinoma.
Al-Taee AM; Mohammed KA; Khneizer GW; Neuschwander-Tetri BA
J Gastrointest Cancer; 2019 Jun; 50(2):357-360. PubMed ID: 31006830
[TBL] [Abstract][Full Text] [Related]
17. Overuse of venous thromboembolism prophylaxis among hospitalized patients with liver disease.
Davis JPE; O'Leary KE; Intagliata NM
Eur J Haematol; 2020 Mar; 104(3):223-229. PubMed ID: 31797441
[TBL] [Abstract][Full Text] [Related]
18. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
Nordstrom BL; Evans MA; Murphy BR; Nutescu EA; Schein JR; Bookhart BK
Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
[TBL] [Abstract][Full Text] [Related]
19. Improved prophylaxis and decreased rates of preventable harm with the use of a mandatory computerized clinical decision support tool for prophylaxis for venous thromboembolism in trauma.
Haut ER; Lau BD; Kraenzlin FS; Hobson DB; Kraus PS; Carolan HT; Haider AH; Holzmueller CG; Efron DT; Pronovost PJ; Streiff MB
Arch Surg; 2012 Oct; 147(10):901-7. PubMed ID: 23070407
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in pediatric trauma patients: Ten-year experience and long-term follow-up in a tertiary care center.
Leeper CM; Vissa M; Cooper JD; Malec LM; Gaines BA
Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28067012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
